|
Page Content Biopolis at one-north is one of JTC’s key projects to boost the biomedical industry as the country’s next engine of economic growth.
As the premier research hub for Biomedical Science, Biopolis hosts key public and private biomedical research institutes and organisations. When fully developed, the Biopolis will anchor the development of the entire research and development (R&D) value chain of life sciences. This will encompass basic drug discovery, clinical development and medical technology research.
Key Customers
Well-known pharmaceutical companies such as Abbott, GSK and Novartis, as well as researchers from the private and public sectors have made Biopolis their home.
Procter & Gamble (P&G), the world’s leading consumer health giant, has taken up the entire Phase 4 of the Biopolis for its Singapore Innovation Centre. The S$250 million Innovation Centre will undertake strategic upstream corporate research through collaborative research with A*STAR, focusing on new innovations for consumers. The facility will house 400 researchers when fully completed in 2013.
|